ICOS drops second patent dispute over erectile dysfunction drug
Healthcare 2019-05-15 12:41 pm By Amelia Birnie Sydney
Please login to bookmark Close

US biotechnology company ICOS has settled a dispute with Australian-based Arrow Pharma over the patents for erectile dysfunction drug Cialis, less than 12 months after a court upheld the validity of the patents in a separate case.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au